SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-216148
Filing Date
2022-08-09
Accepted
2022-08-09 16:09:31
Documents
75
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d354425d10q.htm   iXBRL 10-Q 1171593
2 EX-31.1 d354425dex311.htm EX-31.1 10253
3 EX-31.2 d354425dex312.htm EX-31.2 10238
4 EX-32.1 d354425dex321.htm EX-32.1 4376
5 EX-32.2 d354425dex322.htm EX-32.2 4289
  Complete submission text file 0001193125-22-216148.txt   5743741

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cprx-20220630.xsd EX-101.SCH 49635
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20220630_cal.xml EX-101.CAL 46907
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20220630_def.xml EX-101.DEF 172933
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20220630_lab.xml EX-101.LAB 362391
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20220630_pre.xml EX-101.PRE 287295
69 EXTRACTED XBRL INSTANCE DOCUMENT d354425d10q_htm.xml XML 979533
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 221148348
SIC: 2834 Pharmaceutical Preparations